Table 3 Study and control groups.
Study group | Control group | Differences between groups, P value | |
|---|---|---|---|
hypercoagulability | + | - | - |
number of patients | 28 | 28 | - |
male/female | 20/8 | 21/7 | 0.33 |
median age | 62 | 60.1 | 0.52 |
Prognostic factors | |||
Good prognosis | 15 pts (53.6%) | 15 pts (53.6%) | - |
Poor prognosis | 13 pts (46.4%) | 13 pts (46.4%) | - |